Tarsus Pharmaceuticals, Inc. (TARS)
79.55
-2.68
(-3.26%)
USD |
NASDAQ |
Dec 09, 16:00
78.63
-0.92
(-1.16%)
After-Hours: 07:55
Tarsus Pharmaceuticals Profit Margin (Quarterly): -10.60% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -82.06% |
| Codexis, Inc. | -228.1% |
| Precigen, Inc. | -5.01K% |
| Celcuity, Inc. | -- |
| Liquidia Corp. | -6.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.56% |
| Return on Assets | -17.77% |
| Return on Invested Capital | -22.00% |
| Gross Profit Margin (Quarterly) | 93.00% |
| Operating Margin (Quarterly) | -12.24% |
| Return on Net Operating Assets | -93.55% |